Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

African American men with prostate cancer have more androgen receptor mutations, which may lead to more aggressive cancer compared to Caucasian American men.

Early stage bald spots are linked to skin inflammation and damage to the upper part of the hair follicle.

Scientists have developed a new method to detect steroid abuse in athletes using cell-based tests, which could be the future of anti-doping methods.

Transgender patients need proper skin care, especially when undergoing hormone treatments, to manage issues like acne and hair loss.

Hair and serum levels of zinc, copper, and iron are similar in people with alopecia areata and healthy individuals.

Low vitamin D receptor levels found in hair loss patients; topical vitamin D treatment suggested.

Eosinophilic infiltrate is not a reliable indicator for diagnosing chronic alopecia areata.

Carboxytherapy may help increase hair growth in alopecia patients but requires ongoing treatment.

Alopecia Areata is an autoimmune hair loss condition that needs more research for better treatments.

Low-level laser therapy can stimulate hair growth more effectively than fake devices, but patient satisfaction is similar for both. Results should be taken with caution due to small study sizes and differences between studies. More research is needed.

PRP is effective for hair loss and might work better with other treatments, but more research is needed.

Topical diphencyprone helped regrow hair in mice and rats with a condition similar to human hair loss.

People with alopecia areata may be more likely to have a certain type of hearing loss.

Higher DKK-1 levels found in hair loss patients; L-ascorbic acid 2-phosphate, L-threonate, and ginsenoside F2 may help promote hair growth.

Using methods like lasers and microneedling with drugs can improve hair regrowth for alopecia, but more research is needed on safety and best practices.

Combining imiquimod with diphenylcyclopropenone may improve treatment outcomes for alopecia areata patients who don't respond to diphenylcyclopropenone alone.

Nonsteroid treatments for alopecia areata show promise but need more high-quality research.

Environmental factors like diet and vitamin levels, especially Vitamin D, can affect autoimmune diseases differently, with lifestyle changes potentially improving outcomes.

Injecting platelet-rich plasma or applying it with a laser or microneedling can treat hair loss effectively. The laser and microneedling methods cause less pain.

Platelet-Rich Plasma (PRP), a protein-rich extract from a patient's blood, shows promise in improving hair density, thickness, and quality, but the best method of use and number of treatments needed for noticeable results are still unclear.

A certain genetic variation is linked to a higher risk of polycystic ovarian syndrome.

Oral JAK inhibitors are safe for alopecia areata, but baricitinib may cause more acne and infections.

Oxidative stress may contribute to hair loss in alopecia areata and antioxidants could potentially help as a treatment.

Caffeine shows promise for treating some types of hair loss, but more research is needed.

Biopsy can differentiate between alopecia areata and androgenic alopecia, and if more information is needed, testing for CD3 and CD8 can help.

Scalp biopsies help tell apart androgenetic alopecia and alopecia areata.

Dermatologists' treatment of alopecia areata is inconsistent, especially for children and advanced stages.

More research is needed on alopecia areata treatments and its psychological effects.